Ethaselen (BBSKE) is an orally active and selective thioredoxin reductase 1 (TrxR) inhibitor with anticancer activity that directly inhibits TrxR1 activity and is commonly used in combination with oxaliplatin to inhibit tumor growth.Ethaselen induces apoptosis in cancer cells and inhibits the proliferation of colorectal cancer cells.
Molecular Weight:
422.2
Purity:
97.58%
CAS Number:
[217798-39-5]
Formula:
C16H12N2O2Se2
Target:
Reductase
T39664
* VAT and and shipping costs not included. Errors and price changes excepted